Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk

This study demonstrates the potential of stromal signatures in identification of clinically relevant PC subtypes, and further indicated that stromal characterization may enhance risk stratification in LPC and may be particularly promising in cases with high prognostic ambiguity based on clinical parameters.PMID:38395986 | DOI:10.1038/s41698-024-00540-x

Source: Clinical Prostate Cancer - February 23, 2024 Category: Cancer & Oncology Authors: Martin Rasmussen Jacob Freds øe Paul Vinu Salachan Marcus Pii Lunau Blanke Stine Hesselby Larsen Benedicte Parm Ulh øi J ørgen Bjerggaard Jensen Michael Borre Karina Dalsgaard S ørensen Source Type: research